These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 9256184
1. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Sher LS, Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, Busuttil R, McDiarmid S, Burdick JF, Klein AS, Esquivel C, Klintmalm G, Levy M, Roberts JP, Lake JR, Kalayoglu M, D'Alessandro AM, Gordon RD, Stieber AC, Shaw BW, Thistlethwaite JR, Whittington P, Wiesner RH, Porayko M, Cosimi AB. Transplantation; 1997 Jul 27; 64(2):258-63. PubMed ID: 9256184 [Abstract] [Full Text] [Related]
2. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J. Transplantation; 2000 Jun 27; 69(12):2573-80. PubMed ID: 10910279 [Abstract] [Full Text] [Related]
3. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Jain A, Demetris AJ, Kashyap R, Blakomer K, Ruppert K, Khan A, Rohal S, Starzl TE, Fung JJ. Liver Transpl; 2001 Jul 27; 7(7):623-30. PubMed ID: 11460230 [Abstract] [Full Text] [Related]
4. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW. Ann Surg; 1999 Jun 27; 229(6):824-31; discussion 831-3. PubMed ID: 10363896 [Abstract] [Full Text] [Related]
5. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Millis JM, Woodle ES, Piper JB, Bruce DS, Newell KA, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR. Transplantation; 1996 May 15; 61(9):1365-9. PubMed ID: 8629298 [Abstract] [Full Text] [Related]
6. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients. McDiarmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW. J Pediatr Gastroenterol Nutr; 1995 Apr 15; 20(3):291-9. PubMed ID: 7541834 [Abstract] [Full Text] [Related]
7. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J. Transplantation; 1996 Sep 15; 62(5):594-9. PubMed ID: 8830821 [Abstract] [Full Text] [Related]
9. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP. Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224 [Abstract] [Full Text] [Related]
11. FK506 conversion therapy in pediatric liver transplantation. Egawa H, Esquivel CO, So SK, Cox K, Concepcion W, Lawrence L. Transplantation; 1994 Apr 27; 57(8):1169-73. PubMed ID: 7513911 [Abstract] [Full Text] [Related]
12. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. Selzner N, Durand F, Bernuau J, Heneghan MA, Tuttle-Newhall JE, Belghiti J, Clavien PA. Transplantation; 2001 Sep 27; 72(6):1061-5. PubMed ID: 11579301 [Abstract] [Full Text] [Related]
13. Rejection and tacrolimus conversion therapy in paediatric liver transplantation. Spada M, Corno V, Colledan M, Segalin A, Lucianetti A, Torre G, Riva S, Sonzogni A, Petz W, Gridelli B. Transpl Int; 2000 Sep 27; 13 Suppl 1():S341-4. PubMed ID: 11112028 [Abstract] [Full Text] [Related]
14. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group. Mentzer RM, Jahania MS, Lasley RD. Transplantation; 1998 Jan 15; 65(1):109-13. PubMed ID: 9448154 [Abstract] [Full Text] [Related]
16. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Jain A, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl T, Fung J. Ann Surg; 1999 Sep 15; 230(3):441-8; discussion 448-9. PubMed ID: 10493490 [Abstract] [Full Text] [Related]
17. Conversion to tacrolimus after liver transplantation. Jonas S, Bechstein WO, Lemmens HP, Kling N, Grauhan O, Lobeck H, Neuhaus P. Transpl Int; 1996 Sep 15; 9(1):23-31. PubMed ID: 8748407 [Abstract] [Full Text] [Related]
18. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS. Transplantation; 1998 Jan 27; 65(2):180-7. PubMed ID: 9458011 [Abstract] [Full Text] [Related]
19. The impact on biochemical profiles and allograft function for patients converted from cyclosporine to tacrolimus after clinical heart transplantation. Wang CH, Chou NK, Ko WJ, Chi NH, Tsao CI, Wang SS. Transplant Proc; 2008 Oct 27; 40(8):2600-2. PubMed ID: 18929812 [Abstract] [Full Text] [Related]
20. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW. Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719 [Abstract] [Full Text] [Related] Page: [Next] [New Search]